nivolumab,ipilimumab
bms
['nivo', 'melanoma']
had a great time presenting our work on adaptively dosed ipi-nivo at #asco23 yesterday lots of thoughtful engagement on potential strategies to reduce ici toxicity in melanoma 
medical oncology fellow @mskcancercenter I interested in melanoma  & novel immunotherapies. 

n.b.: personal account, views not representative of MSK